Tartu University spin-off Vectiopep is developing a novel cancer treatment technology that leverages the body’s natural immune response to combat the disease. The company is focused on developing technologies that activate the immune system to target and destroy cancer cells. Vectiopep’s approach utilizes the body’s own defenses to address cancer, representing a potential new avenue in cancer treatment. Topics: #cancer #technologies #vectiopep Post navigation The official of Hiiumaa who was buried under the snow in the forest after being killed by a fox won the court in a net commentator The March 1949 deportation memorial concert features the extraordinary music piece by Robert Jürjendal
This is a really promising development in the fight against cancer, and I’m excited to see what Vectiopep achieves. Reply
What is the specific mechanism Vectiopep uses to activate the immune system against cancer cells? Reply